On September 29, 2020, Salience Learning and the Life Sciences Trainers & Educators Network (LTEN) collaborated on a webinar entitled, COVID-19: Then, Now and What’s Next. From this page, readers can download a copy of the PowerPoint presentation used to facilitate that webinar.

Webinar Description:

This webinar highlighted the challenges Learning & Development (L&D) teams face when training customer-facing field teams now that COVID-19 has driven much activity to a virtual environment. It also explored examples for how L&D should “deconstruct the do” for the top two customer-facing skills in the virtual selling environment.

Speakers:

Karen Foster, Head of Learning Strategy and Solutions, SalienceLearning

Alicia Talish, Lead—Worldwide Training; Leadership and Talent Development, Bristol-Myers Squibb.

As the global economy evolves, pharmaceutical companies are becoming increasingly global in their mindsets and actions.  As a result, L&D teams must work more effectively across markets to achieve business objectives.

For L&D, “going global” can offer a range of benefits. However, there are challenges that L&D teams must address as they transition to a global footprint.

This paper collects input that was shared at a workshop on this topic at the LTEN Annual Meeting in Grapevine, TX on June 4, 2019. The workshop was led by George Schmidt of Salience Learning and Kerstin Hartig of Bristol-Myers Squibb. This paper outlines the following:

1. Why Should L&D Work Globally?
2. Benefits of a Global Footprint
3. Key Challenges Associated with Going Global.
4. Addressing the Challenges: Potential Solutions and Lessons Learned from BMS’ Transition to a Global L&D Organization